2Apostolidou E,Swords R,Alvarado Y.el a1.Treatment of acute lymphoblastie leukaemia:a new era[J].Drugs.2007,67:2153-2171.
3Mitchell GL,Maureen A,Kim H,et a1.Trend to delicacy and safety using antithrombrombin concentrate in prevention of thrombosisi in children receiving L-asparaginase for acute lymphoblastic leukemia[J].Thromb Haemost,2003,90:235-244.
4W1azlowski M,Celinska W,Maciejka Kapuscinska L,et a1.Acute pancreatitis in children with acute lymphoblatic leukemia treated with L-asparaginase[J].Pol Tyg Lek.1994,49(12-13):296.
5Greenstrein R,Nogeire C,Ohnuma T.et al.Management of L-asparaginase induced hemorrhagic pancreatitis complicated by pseudocyst[J].Cancer.1998,43(7):382.
2Nachman JB, Sather HN, Sensel MG, et al, Augmented postinduction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med,1998; 338:1663 -1671
3Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital,Blood, 2004; 104:2690-2696
5Carroll WL, Bhojwani D, Min DJ, et al. Pediatric acute lymphoblastic leukemia. Hematology, 2003, 1 : 102 - 131
6Ramakers vall Woerden NL, Pieters R, Loonen AH, et al.TELAML1 gene fusion is related to in vitro drug sensitivity for Lasparaginase in childhood acute lymphoblastic leukemia. Blood,2000; 96:1094-1099
7Loh ML, Silverrnan LB, Young ML, et al. Incidence of TEL/AML1 fusion in children with relapsed acute lymphoblastic leukemia. Blood, 1998; 92:4792 -4797
8Seeger K, Buchwald D, Peter A, et al. TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia, Blood, 1999;94: 374 - 376
9Pui CH, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukemia with rearrangements of the 11q23 chromosomal region. Lancet, 2002; 359(9321 ): 1909 -1915
10Stare RW, den-Boer ML, Meijerink JP, et al. Differential mRNA expression of Axa-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia, Blood, 2003; 101 : 1270 -1276
